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Abstract
Background: Primary hepatic carcinoid tumor (PHCT) is very rare and difficult to diagnose before
biopsy or operation. We report a patient with a small PHCT and review cases in the literature.
Case presentation: A 48-year-old Chinese female with underlying hepatitis B virus (HBV)
infection was found to have a low echoic hepatic nodule by abdominal ultrasound. Tumor markers
were negative. Dynamic liver computed tomography scans showed enhancement of the nodule in
the arterial phase and early washout in the portal phase. Hepatocellular carcinoma (HCC) was
considered based on the image findings and underlying HBV infection. However, the tumor biopsy
revealed a malignant neoplasm that originating from neuroendocrine cells. Pre-operative and intra-
operative investigations for the possible other origin of carcinoid tumor were negative, so PHCT
was confirmed.
Conclusion: A small and asymptomatic PHCT is extremely rare. PHCT should be one of the
differential diagnoses in patients with small hepatic tumor, even in regions with high prevalence of
HBV infection and HCC. Pre-operative biopsy is necessary to avoid misdiagnosis even when HCC
is highly suspected clinically.
Background
Carcinoid tumors are neuroendocrine origin neoplasm
and may produce serotonin or other functional peptide
hormones. They are well-differentiated and low-grade
malignant neoplasms. Approximately 74% of all carci-
noid tumors arise from the gastrointestinal (GI) tract and
the liver is a common site for metastases [1]. However,
primary hepatic carcinoid tumor (PHCT) is very rare and
the first case was documented by Edmondson in 1958 [2].
This rarity makes it difficult for clinicians to diagnose
accurately before biopsy, resection of tumor, or autopsy
[3]. Large-sized tumors are common presentations when
they are diagnosed [4]. PHCT presents as a small and sin-
gle nodule, is extremely rare and is difficult to differentiate
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from hepatocellular carcinoma (HCC), particularly in a
region with high prevalence of HCC. Herein, we report a
rare case of small PHCT with underlying HBV infection
which was suspected to be a small HCC before operation
and also comprehensively review 94 cases of PHCT in the
literature.
Case presentation
A 48-year-old Chinese female with HBV infection for 15
years was regularly followed up at gastroenterology outpa-
tient department by abdominal ultrasound (US) and
serum alpha-fetoprotein (AFP) screening every six
months. In May 2005, abdominal US demonstrated a low
echoic nodule, 1.6 × 1.6 cm in size in the sixth segment of
the liver and mild parenchymal liver disease (Fig. 1A). She
was asymptomatic and no abnormality was disclosed by
physical examination. Noncontrast liver computed tom-
ography (CT) showed a 1.6 × 1.6 cm well-circumscribed
and low density nodule in the same liver segment (Fig.
1B). Dynamic CT scans showed enhancement of the nod-
ule in the arterial phase and early washout in the portal
phase (Figs. 1C and 1D). Serum was positive for hepatitis
B surface antigen (HBsAg), but negative for HBeAg. The
serum anti-HCV was also negative. AFP and CEA were
within normal range. Based on the imaging findings and
underlying HBV infection, small HCC was highly sus-
pected and a US-guided liver biopsy was performed for
definite diagnosis. However, the pathological finding sug-
gested a malignant neoplasm originating form neuroen-
docrine cells (Fig. 2A). The result of
(A) Abdominal ultrasound shows a low echoic nodule in the sixth segment of the liver (arrowheads) Figure 1
(A) Abdominal ultrasound shows a low echoic nodule in the sixth segment of the liver (arrowheads). (B) Non-
contrast CT scan shows a well-circumscribed, low density nodule (arrowheads). (C) Dynamic CT scan shows enhancement of 
the nodule in the arterial phase (arrowheads). (D) Dynamic CT scan shows enhancement in the portal phase (arrowheads).Cases Journal 2009, 2:90 http://www.casesjournal.com/content/2/1/90
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 immunohistochemical (IHC) stain was positive for neu-
ron-specific enolase (NSE), synaptophysin, and chrom-
ogranin A (Fig. 2B). The pre-operative 24-hour urine 5-
hydroxyindoleacetic acid (5-HIAA) value was within nor-
mal limits. We undertook a more thorough investigation
to rule out the possibility that the liver tumor was a meta-
static carcinoid. This workup included upper and low GI
endoscopy, a small bowel series, abdominal US, and chest
and abdominal CT scans. All imaging findings were unre-
markable. Partial hepatectomy was performed. Small
bowel, appendix and large bowel were checked during
operation and no tumor was found. No cirrhotic liver was
noted. The surgery was performed successfully and the
patient recovered well. The resected liver tissue contained
a 1.6 × 1.6 × 1.5 cm circumscribed tumor (Fig. 3). Histo-
logical examination revealed the round or ovoid neoplas-
tic cells arranged in insular pattern with a rosette
formation. There was no tumor embolus in the vessels
and the resection line was free from tumor invasion. The
IHC stains were positive for chromogranin A, cytokeratin,
NSE, and synaptophysin. The final diagnosis was PHCT.
She was followed up regularly at our hospital and
remained disease-free 3 years after operation.
Discussion
The origin of PHCT remains unknown. The cells may orig-
inate from ectopic pancreatic or adrenal tissue found
within the liver or from scattered neuroendocrine cells in
the intrahepatic biliary epithelium [5]. Some were
observed in animal studies such as those found in the rat
liver [6]. The scarcity of such cells may explain the rarity of
primary hepatic neuroendocrine tumors. It is also pro-
posed that chronic inflammation in the biliary system
may induce intestinal metaplasia that predisposes to the
development of neuroendocrine tumor [5].
(A) The tumor was composed of round or ovoid cells arranged in insular pattern with a rosette formation (hematoxylin and  eosin) Figure 2
(A) The tumor was composed of round or ovoid cells arranged in insular pattern with a rosette formation 
(hematoxylin and eosin). (B) The tumor cells were positive for chromogranin A.
The resected liver contained a 1.6 × 1.6 × 1.5 cm circum- scribed tumor (arrowheads) Figure 3
The resected liver contained a 1.6 × 1.6 × 1.5 cm cir-
cumscribed tumor (arrowheads).Cases Journal 2009, 2:90 http://www.casesjournal.com/content/2/1/90
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Including our case, we found 94 cases of PHCT (including
primary hepatic neuroendocrine tumor) in the literature
[1-5,7-15] and their clinical characteristics are summa-
rized in Table 1. This type of tumor occurs mainly in mid-
dle age (mean age, 49.8 years) and is slightly more
frequent in females (58.5%). The most common symp-
tom among 84 cases was abdominal pain (37 cases,
44.0%). Eleven cases were asymptomatic (13.1%). The
overall mortality rate was 25.5% (24/94) as shown in
Table 2.
The case we presented was a small and asymptomatic
PHCT. In the literature, only 9.5% (7/74) and 13.1% (11/
84) of cases were small-sized tumors ( 3 cm) and
asymptomatic PHCTs, respectively. Their prognosis was
good and the survival rate was 100 % for the 7 small-sized
tumor cases and 90.1% (10/11) for the asymptomatic
cases, only one of which died as a result of renal cell car-
cinoma.
The rarity of PHCT makes it difficult to diagnose accu-
rately before biopsy or resection. In previous reports, 4
(4.3%) and 5 (5.3%) cases were diagnosed as HCC [8-10]
and cholagiocarcinoma [11,12] respectively by imaging
and clinical findings before operation. Moreover, PHCT is
also difficult to diagnose because of the histological simi-
larity with HCC [3]. 11.7% (11/94) of cases were misdiag-
nosed as HCC by light microscopy until they revealed the
features of carcinoid tumor by IHC examinations
[3,7,9,13]. Furthermore, 6 (6.4%) cases had chronic liver
disease with HBV or HCV infection and 3 (3.2%) cases
with HBV infection were misdiagnosed as HCC before
IHC stains [9,14,15]. Our case had the underlying hepati-
tis B liver disease and typical imaging presentation of
HCC in dynamic CT scans. AFP level may not rise due to
small size of tumor. In addition, Taiwan is a region with
high prevalence of HBV and HCC. Thus, small HCC was
highly suspected before biopsy. Carcinoid tumor was con-
firmed by liver biopsy and we arranged serial pre-opera-
Table 1: Clinical characteristics and imaging findings of 94 cases of primary hepatic carcinoid tumor
Characteristics Number (%)
Age (y)a 49.8 ± 16.0
Gender (M/F) 39/55 (41.5/58.5)
Clinical manifestations
Asymptomatic 11/84 (13.1)
Abdominal pain 37/84 (44.0)
Carcinoid syndrome 14/84 (16.7)
Diarrhea 8/84 (9.5)
Flushing 4/84 (4.8)
Cushing syndrome 2/84 (2.4)
Abdominal mass 12/84 (14.3)
Fatigue 6/84 (7.1)
Zollinger-Ellison syndrome 5/84 (6.0)
Dyspnea 4/84 (4.8)
Jaundice 4/84 (4.8)
Anemia 2/84 (2.4)
Body weight loss 2/84 (2.4)
Hypoglycermia 1/84 (1.2)
Leg edema 1/84 (1.2)
Imaging finings
Ultrasound
Solid tumor 32/39 (82.1)
Solid tumor with cystic component 7/39 (17.9)
Hyperechoic pattern 12/14 (85.7)
Hypoechoic pattern 2/14 (14.3)
Computed tomography
Low density tumor in noncontrast 37/50 (74.0)
Low density tumor with cystic component in noncontrast 17/50 (34.0)
Tumor enhancement 20/50 (40.0)
Enhanced in arterial phase and washout in portal phase 13/50 (26.0)
Magnetic resonance imaging
Low intensity in T1 and high intensity in T2 17/21 (81.0)
Angiography
Hypervascular tumor 23/27 (85.2)
Avascular tumor 4/27 (14.8)
aPresent as mean value ± standard derivationCases Journal 2009, 2:90 http://www.casesjournal.com/content/2/1/90
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tive and intra-operative examination to investigate the
original site of tumor because the liver is a common site
for metastases of carcinoid tumors [1]. The accurate diag-
nosis of carcinoid tumor before operation is very impor-
tant because it can alert clinicians to seek possible sites of
metastasis, thereby avoiding unnecessary operation or a
second operation if a metastatic lesion is found.
Conclusion
A small and asymptomatic PHCT is extremely rare. PHCT
should be one of the differential diagnoses in patients
with small hepatic tumor, even in regions with high prev-
alence of HBV infection and HCC. Pre-operative biopsy is
necessary to avoid misdiagnosis even when HCC is highly
suspected clinically.
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Table 2: Location of tumor, histology and prognosis of 94 cases of primary hepatic carcinoid tumor
Characteristics Number (%)
Location
unilobar 72/94 (76.6)
Left lobe 28/94 (29.8)
Right lobe 44/94 (46.8)
billobar 22/94 (23.4)
Number
Single 59/94 (62.8)
Multiple 35/94 (37.2)
Tumor size
 3 cm 7/74 (9.5)
> 3 cm 67/74 (90.5)
Histological stains
Grimelius 64/71 (90.1)
Fontana-Masson stains 14/34 (41.2)
Immunohistochemical stains
Chromogranin A 57/64 (89.1)
Neuron specific enolase 43/58 (74.1)
Synaptophysin 23/47 (48.9)
cytokeratin 22/40 (55.0)
Misdiagnosed as HCC by microscopy before IHC stains 11/94 (11.7)
Prognosis
Alive 70/94 (74.5)
Death 24/94 (25.5)
Treatment
Hepatectomy 73/84 (86.8)
Liver transplantation 3/84 (3.6)
Transcatheter arterial embolization 3/84 (3.6)
Chemotherapy 2/84 (2.4)
Radiotherapy 2/84 (2.4)
Radiofrequency ablation 1/84 (1.2)
Recurrence
No recurrence 53/75 (70.7)
Recurrence 22/75 (29.3)
HCC: Hepatocellular Carcinoma; IHC: Immunohistochemical;Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cases Journal 2009, 2:90 http://www.casesjournal.com/content/2/1/90
Page 6 of 6
(page number not for citation purposes)
tion of the patient and was a major contributor in writing
the manuscript; KH performed the images investigation of
the patient and was a major contributor in writing the
manuscript; CL contributed to the writing and revising of
the manuscript; YC contributed to the writing and revising
of the manuscript.
All authors read and approved the final manuscript.
References
1. Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW: Long-
term survival after resection for primary hepatic carcinoid
tumor.  Annals of surgical oncology 2003, 10(10):1171-5.
2. Edmondson. H: Tumor of the liver and intrahepatic bile duct.
Atlas of tumor pathology, section 7, fascicle 25 Armed Forces Institute of
Pathology, Washington, DC 1958:105-9.
3. Sano K, Kosuge T, Yamamoto J, et al.: Primary hepatic carcinoid
tumors confirmed with long-term follow-up after resection.
Hepato-gastroenterology 1999, 46(28):2547-50.
4. Iwao M, Nakamuta M, Enjoji M, et al.: Primary hepatic carcinoid
tumor: case report and review of 53 cases.  Med Sci Monit 2001,
7(4):746-50.
5. Gravante G, De Liguori Carino N, Overton J, Manzia TM, Orlando G:
Primary carcinoids of the liver: a review of symptoms, diag-
nosis and treatments.  Digestive surgery 2008, 25(5):364-8.
6. Payne CM, Nagle RB, Paplanus SH, Graham AR: Fibrolamellar car-
cinoma of liver: a primary malignant oncocytic carcinoid?
Ultrastruct Pathol 1986, 10(6):539-52.
7. Yasoshima H, Uematsu K, Sakurai K, et al.: Primary hepatic carci-
noid tumor.  Acta pathologica japonica 1993, 43(12):783-9.
8. Asakawa T, Tomioka T, Abe K, et al.: Primary hepatic carcinoid
tumor.  Journal of gastroenterology 1999, 34(1):123-7.
9. Fenwick SW, Wyatt JI, Toogood GJ, Lodge JP: Hepatic resection
and transplantation for primary carcinoid tumors of the
liver.  Annals of surgery 2004, 239(2):210-9.
10. Iimuro Y, Deguchi Y, Ueda Y, et al.: Primary hepatic carcinoid
tumor with metachronous lymph node metastasis after
long-term follow up.  Journal of gastroenterology and hepatology
2002, 17(10):1119-24.
11. Miura K, Shirasawa H: Primary carcinoid tumor of the liver.
American journal of clinical pathology 1988, 89(4):561-4.
12. Krishnamurthy SC, Dutta V, Pai SA, et al.:  Primary carcinoid
tumor of the liver: report of four resected cases including
one with gastrin production.  Journal of surgical oncology 1996,
62(3):218-21.
13. Wang CY, Chen A, Tseng HH, et al.: Carcinoid tumor localized in
the liver – two cases report: immunohistochemical and
ultrastructural studies.  Zhonghua yi xue za zhi = Chinese medical
journal; Free China ed 1992, 49(5):365-72.
14. Andreola S, Lombardi L, Audisio RA, et al.: A clinicopathologic
study of primary hepatic carcinoid tumors.  Cancer 1990,
65(5):1211-8.
15. Barsky SH, Linnoila I, Triche TJ, Costa J: Hepatocellular carci-
noma with carcinoid features.  Human pathology 1984,
15(9):892-4.